The prostate: MR imaging and spectroscopy. Present and future.

[1]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[2]  J Kurhanewicz,et al.  Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.

[3]  R. Franklin,et al.  Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer , 1998, The Prostate.

[4]  J. Kurhanewicz,et al.  Detection of recurrent prostate cancer after cryosurgery. , 1998, Current opinion in urology.

[5]  J Kurhanewicz,et al.  Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. , 1998, Radiology.

[6]  R. Montironi,et al.  Pathological changes in prostate lesions after androgen manipulation. , 1998, Journal of clinical pathology.

[7]  R. Franklin,et al.  Zinc Inhibition of Mitochondrial Aconitase and Its Importance in Citrate Metabolism of Prostate Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[8]  J A Swets,et al.  Prostate cancer: relative effects of demographic, clinical, histologic, and MR imaging variables on the accuracy of staging. , 1997, Radiology.

[9]  J. Kurhanewicz,et al.  Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing) , 1997, Magnetic resonance in medicine.

[10]  J. Pauly,et al.  Improved solvent suppression and increased spatial excitation bandwidths for three‐dimensional press CSI using phase‐compensating spectral/spatial spin‐echo pulses , 1997, Journal of magnetic resonance imaging : JMRI.

[11]  D. Gillatt,et al.  A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. , 1997, British journal of urology.

[12]  J R Thornbury,et al.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.

[13]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[14]  M. van der Graaf,et al.  In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. , 1997, Anticancer research.

[15]  R Alagappan,et al.  Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. , 1997, Radiology.

[16]  J A Smith,et al.  Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial. , 1997, The Journal of urology.

[17]  JeremyK. Nicholson,et al.  Proton MRS of human prostatic fluid: Correlations between citrate, spermine, and myo‐inositol levels and changes with disease , 1997, The Prostate.

[18]  M. van der Graaf,et al.  Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin‐echo pulse sequence , 1997, Magnetic resonance in medicine.

[19]  R. Franklin,et al.  Prolactin and testosterone regulation of mitochondrial zinc in prostate epithelial cells , 1997, The Prostate.

[20]  G P Liney,et al.  In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. , 1997, Magnetic resonance imaging.

[21]  J A Swets,et al.  Staging prostate cancer with MR imaging: a combined radiologist-computer system. , 1997, Radiology.

[22]  R. Franklin,et al.  Testosterone and prolactin stimulation of mitochondrial aconitase in pig prostate epithelial cells. , 1996, Urology.

[23]  P. Carroll,et al.  Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. , 1996, Urology.

[24]  S. Blackband,et al.  Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age‐related differences , 1996, Magnetic resonance in medicine.

[25]  P. Carroll,et al.  Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. , 1996, Radiology.

[26]  J. Muscat,et al.  Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer , 1996, Abdominal Imaging.

[27]  M. Gleave,et al.  Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer. , 1996, Urology.

[28]  P. Carroll,et al.  Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. , 1996, AJR. American journal of roentgenology.

[29]  G P Liney,et al.  Proton MR T2 Maps Correlate With The Citrate Concentration in the Prostate , 1996, NMR in biomedicine.

[30]  M D Schnall,et al.  Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer. , 1996, Academic radiology.

[31]  J R Thornbury,et al.  Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. , 1996, AJR. American journal of roentgenology.

[32]  J Kurhanewicz,et al.  Prostate carcinoma: MR imaging findings after cryosurgery. , 1996, Radiology.

[33]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[34]  P. Carroll,et al.  Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. , 1996, AJR. American journal of roentgenology.

[35]  A. Partin,et al.  Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment? , 1995, Urology.

[36]  R. Franklin,et al.  Testosterone stimulates the biosynthesis of m-aconitase and citrate oxidation in prostate epithelial cells , 1995, Molecular and Cellular Endocrinology.

[37]  P. Carroll,et al.  Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.

[38]  A. Heerschap,et al.  In vitro proton magnetic resonance spectroscopy of four human prostate cancer cell lines , 1995, The Prostate.

[39]  S. Nelson,et al.  Surface coil MR imaging of the human brain with an analytic reception profile correction , 1995, Journal of magnetic resonance imaging : JMRI.

[40]  J Kurhanewicz,et al.  Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.

[41]  P. Carroll,et al.  Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.

[42]  Richie Jp,et al.  Management of patients with positive surgical margins following radical prostatectomy. , 1994 .

[43]  D. Mitchell,et al.  Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. , 1994, Radiology.

[44]  A. Partin,et al.  Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. , 1994, The Journal of urology.

[45]  Y. Furuya,et al.  The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue. , 1994, Seminars in cancer biology.

[46]  R. Franklin,et al.  Bioenergetic theory of prostate malignancy , 1994, The Prostate.

[47]  C W Piccoli,et al.  Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. , 1994, Radiology.

[48]  T. Uchida,et al.  [Usefulness and limitation of digital rectal examination and imaging studies in staging prostate cancer]. , 1994, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[49]  R. Franklin,et al.  Effect of prolactin on the prostate , 1994, The Prostate.

[50]  K. Sugimura,et al.  Benign prostatic hyperplasia: value of MR imaging for determining histologic type. , 1994, Radiology.

[51]  M. Spraul,et al.  Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. , 1994, Journal of pharmaceutical and biomedical analysis.

[52]  A. Heerschap,et al.  Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy. , 1993, The Journal of urology.

[53]  J. Epstein,et al.  Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels? , 1993, The Journal of urology.

[54]  D. Chan,et al.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.

[55]  R. Herfkens,et al.  Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil. , 1993, AJR. American journal of roentgenology.

[56]  D. Bostwick,et al.  Staging of early prostate cancer: a proposed tumor volume-based prognostic index. , 1993, Urology.

[57]  J. Mohler,et al.  In vitro high resolution 1h‐spectroscopy of the human prostate: Benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma , 1993, Magnetic resonance in medicine.

[58]  J. Kurhanewicz,et al.  Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study , 1993, Magnetic resonance in medicine.

[59]  F. Schick,et al.  Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 T , 1993, Magnetic resonance in medicine.

[60]  J. Kurhanewicz,et al.  Phosphorus metabolite characterization of human prostatic adenocarcinoma in a nude mouse model by 31P magnetic resonance spectroscopy and high pressure liquid chromatography , 1992, NMR in biomedicine.

[61]  A. Fowler,et al.  Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR , 1992, Magnetic resonance in medicine.

[62]  D. Gleason,et al.  Histologic grading of prostate cancer: a perspective. , 1992, Human pathology.

[63]  J Kurhanewicz,et al.  Magnetic resonance spectroscopy in prostate disease: Diagnostic possibilities and future developments , 1992, The Prostate. Supplement.

[64]  M. Weiner,et al.  31P spectroscopy of the human prostate gland in vivo using a transrectal probe , 1991, Magnetic resonance in medicine.

[65]  K. Taber,et al.  Magnetic resonance imaging of the efficacy of specific inhibition of 5α‐reductase in canine spontaneous benign prostatic hyperplasia , 1991 .

[66]  J. Kurhanewicz,et al.  Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report. , 1991, The Journal of urology.

[67]  R E Lenkinski,et al.  Prostate cancer: local staging with endorectal surface coil MR imaging. , 1991, Radiology.

[68]  C. Gatsonis,et al.  Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. , 1990, The New England journal of medicine.

[69]  R. Franklin,et al.  Concepts of citrate production and secretion by prostate: 2. Hormonal relationships in normal and neoplastic prostate , 1991, The Prostate.

[70]  R. Franklin,et al.  Concepts of citrate production and secretion by prostate 1. Metabolic relationships , 1991, The Prostate.

[71]  J. Kurhanewicz,et al.  1H MR spectroscopy of normal and malignant human prostates in Vivo , 1990 .

[72]  J. Lewin,et al.  Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. , 1989, Radiology.

[73]  D. Vigneron,et al.  Transrectal probe for 1H MRI and 31P MR spectroscopy of the prostate gland , 1989, Magnetic resonance in medicine.

[74]  R E Lenkinski,et al.  Prostate: MR imaging with an endorectal surface coil. , 1989, Radiology.

[75]  L Axel,et al.  Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. , 1989, Radiology.

[76]  D. Gadian,et al.  31P magnetic resonance spectroscopy of the normal human brain: approaches using four dimensional chemical shift imaging and phase mapping techniques , 1989, NMR in biomedicine.

[77]  H. Bruhn,et al.  Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.

[78]  R. Griffey,et al.  In Vivo 13C NMR Spectroscopy of the Human Prostate , 1988, Magnetic resonance in medicine.

[79]  T. Stamey,et al.  Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.

[80]  J. Martin,et al.  Inflatable surface coil for MR imaging of the prostate. , 1988, Radiology.

[81]  P. Bottomley.  Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[82]  L. Kivisaari,et al.  Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic cancer before radical retropubic prostatectomy. , 1987, The Journal of urology.

[83]  S K Hilal,et al.  In vivo MR spectroscopic imaging with P-31. Work in progress. , 1984, Radiology.

[84]  Thomas H. Mareci,et al.  High-resolution magnetic resonance spectra from a sensitive region defined with pulsed field gradients , 1984 .

[85]  P. Walsh,et al.  Estrogen receptors in human prostate: evidence for multiple binding sites. , 1983, The Journal of clinical endocrinology and metabolism.

[86]  D. Bostwick,et al.  Radiation injury of the normal and neoplastic prostate , 1982, The American journal of surgical pathology.

[87]  I. Campbell,et al.  Proton nuclear magnetic resonance of intact Friend leukemia cells: phosphorylcholine increase during differentiation. , 1982, Science.

[88]  K. Uğurbil,et al.  NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[89]  Rameshwar K. Sharma,et al.  Endocrine control in neoplasia , 1978 .

[90]  Zontine Wj.  The prostate gland. , 1975 .

[91]  J. F. Cooper,et al.  THE ROLE OF CITRIC ACID IN THE PHYSIOLOGY OF THE PROSTATE. 3. LACTATE/CITRATE RATIOS IN BENIGN AND MALIGNANT PROSTATIC HOMOGENATES AS AN INDEX OF PROSTATIC MALIGNANCY. , 1964, The Journal of urology.

[92]  J F COOPER,et al.  The role of citric acid in the physiology of the prostate. A chromatographic study of citric acid cycle intermediates in benign and malignant prostatic tissue. , 1963, The Journal of surgical research.

[93]  T. Mann,et al.  Citric Acid in Human Prostatic Secretion and Metastasizing Cancer of Prostate Gland , 1962, British medical journal.